Study: People worldwide living longer, but sicker


LONDON (AP) — Nearly everywhere around the world, people are living longer and fewer children are dying. But increasingly, people are grappling with the diseases and disabilities of modern life, according to the most expansive global look so far at life expectancy and the biggest health threats.


The last comprehensive study was in 1990 and the top health problem then was the death of children under 5 — more than 10 million each year. Since then, campaigns to vaccinate kids against diseases like polio and measles have reduced the number of children dying to about 7 million.


Malnutrition was once the main health threat for children. Now, everywhere except Africa, they are much more likely to overeat than to starve.


With more children surviving, chronic illnesses and disabilities that strike later in life are taking a bigger toll, the research said. High blood pressure has become the leading health risk worldwide, followed by smoking and alcohol.


"The biggest contributor to the global health burden isn't premature (deaths), but chronic diseases, injuries, mental health conditions and all the bone and joint diseases," said one of the study leaders, Christopher Murray, director of the Institute of Health Metrics and Evaluation at the University of Washington.


In developed countries, such conditions now account for more than half of the health problems, fueled by an aging population. While life expectancy is climbing nearly everywhere, so too are the number of years people will live with things like vision or hearing loss and mental health issues like depression.


The research appears in seven papers published online Thursday by the journal Lancet. More than 480 researchers in 50 countries gathered data up to 2010 from surveys, censuses and past studies. They used statistical modeling to fill in the gaps for countries with little information. The series was mainly paid for by the Bill & Melinda Gates Foundation.


As in 1990, Japan topped the life expectancy list in 2010, with 79 for men and 86 for women. In the U.S. that year, life expectancy for men was 76 and for women, 81.


The research found wide variations in what's killing people around the world. Some of the most striking findings highlighted by the researchers: — Homicide is the No. 3 killer of men in Latin America; it ranks 20th worldwide. In the U.S., it is the 21st cause of death in men, and in Western Europe, 57th.


— While suicide ranks globally as the 21st leading killer, it is as high as the ninth top cause of death in women across Asia's "suicide belt," from India to China. Suicide ranks 14th in North America and 15th in Western Europe.


— In people aged 15-49, diabetes is a bigger killer in Africa than in Western Europe (8.8 deaths versus 1 death per 100,000).


— Central and Southeast Asia have the highest rates of fatal stroke in young adults at about 15 cases per 100,000 deaths. In North America, the rate is about 3 per 100,000.


Globally, heart disease and stroke remain the top killers. Reflecting an older population, lung cancer moved to the 5th cause of death globally, while other cancers including those of the liver, stomach and colon are also in the top 20. AIDS jumped from the 35th cause of death in 1990 to the sixth leading cause two decades later.


While chronic diseases are killing more people nearly everywhere, the overall trend is the opposite in Africa, where illnesses like AIDS, malaria and tuberculosis are still major threats. And experts warn again shifting too much of the focus away from those ailments.


"It's the nature of infectious disease epidemics that if you turn away from them, they will crop right back up," said Jennifer Cohn, a medical coordinator at Doctors Without Borders.


Still, she acknowledged the need to address the surge of other health problems across Africa. Cohn said the agency was considering ways to treat things like heart disease and diabetes. "The way we treat HIV could be a good model for chronic care," she said.


Others said more concrete information is needed before making any big changes to public health policies.


"We have to take this data with some grains of salt," said Sandy Cairncross, an epidemiologist at the London School of Hygiene and Tropical Medicine.


He said the information in some of the Lancet research was too thin and didn't fully consider all the relevant health risk factors.


"We're getting a better picture, but it's still incomplete," he said.


___


Online:


www.lancet.com


http://healthmetricsandevaluation.org


Read More..

S&P 500 ends six days of gains on "cliff" worries

NEW YORK (Reuters) - The S&P 500 ended its six-day winning streak on Thursday, retreating as worries intensified that Washington's "fiscal cliff" negotiations were dragging on with little progress.


Anxiety about the drawn-out talks between Democrats and Republicans was enough to offset encouraging data on retail sales and jobless claims on Thursday.


There is concern that tax hikes and spending cuts, set to begin in 2013 if a deal is not reached in Washington, will hurt growth. The stock market has taken the heated rhetoric in stride of late, but downbeat remarks from Republican House Speaker John Boehner prompted some selling on Thursday.


Boehner accused President Barack Obama of "slow walking" the economy off the fiscal cliff. He is scheduled to meet with Obama later on Thursday.


"There is no conviction here and Boehner's comments - as harsh as they were - were realistic," said Jason Weisberg, managing director at Seaport Securities Corp., in New York.


"The fiscal cliff is already built in. That being said, people don't like to be told the apocalypse is coming over and over and over again. The real players in this market have already closed their books."


After coming close to a 1 percent decline for the day, the S&P 500 pared losses late in the session. The index had posted six straight sessions of gains through Wednesday's close, and at one point on Wednesday, the S&P touched its highest intraday level since October 22.


While the Federal Reserve's announcement on Wednesday of a new round of economic stimulus bolstered stocks, Chairman Ben Bernanke's comments that monetary policy would not be sufficient to offset the impact of the fiscal cliff weighed on sentiment.


Apple's stock , down 1.7 percent at $529.69, was among the biggest drags on the Nasdaq in Thursday's session, while International Business Machines , down 0.5 percent at $191.99, was among the biggest weights on the Dow. A U.S. jury found that Apple's iPhone infringed three patents owned by MobileMedia Ideas.


Among the day's biggest gainers, Best Buy Co shares shot up 15.9 percent to $14.12 after a report that the company's founder is expected to offer to buy the consumer electronics retailer by the end of the week.


The Dow Jones industrial average <.dji> tumbled 74.73 points, or 0.56 percent, to 13,170.72 at the close. The Standard & Poor's 500 Index <.spx> fell 9.03 points, or 0.63 percent, to 1,419.45. The Nasdaq Composite Index <.ixic> slid 21.65 points, or 0.72 percent, to end at 2,992.16.


Energy and information technology sectors were the S&P 500's weakest performers, with the S&P energy index <.gspe> down 0.9 percent.


In the energy sector, shares of Nabors Industries Ltd dropped 4.7 percent to $13.85 after Jefferies cut the drilling company's rating. Shares of U.S. refining company Phillips 66 lost 1.6 percent to $52.21.


The day's economic data sent some positive signals on the economy, with weekly claims for jobless benefits dropping to nearly the lowest level since February 2008, and retail sales rising in November after an October decline, improving the picture for consumer spending.


In Europe, European Union finance ministers reached agreement to make the European Central Bank the bloc's top banking supervisor, which could boost confidence in EU leaders' ability to confront the euro zone's sovereign debt crisis.


Volume was roughly 6.11 billion shares traded on the New York Stock Exchange, the Nasdaq and the NYSE MKT, compared with the year-to-date average daily closing volume of 6.52 billion.


Decliners outnumbered advancers on the NYSE by a ratio of about 7 to 3, and on the Nasdaq, more than five stocks fell for every three that rose.


(Reporting by Caroline Valetkevitch; Additional reporting by Chuck Mikolajczak; Editing by Kenneth Barry and Jan Paschal)



Read More..

IHT Rendezvous: In China, Fears Ours Would Be a 'One-Week Puppy'

BEIJING — China has many genuine pet lovers who care well for their dogs, but also many owners who don’t. The dog trade is virtually unsupervised and selling sick animals to unsuspecting customers is common. Animal shelters are full. The pet scene is tough. Buying a dog, which I write about in my latest Letter from China, can be a risky business.

“Some breeders just want to make money. Some are real animal lovers,” said Xing Xiaosi, an editor and marketer at goumin.com, a Web site for dog lovers in China that offers an interactive education and information platform.

“But in general, the situation isn’t that positive or optimistic,” she said.

A week after we bought our boxer puppy, Xiao Tongzhi, or Little Comrade, he fell ill.

Knowing the horror stories, I took him to the vet, feeling queasy.

Here’s how Ms. Xing described an all-too common scenario: “Many dogs are not well treated in kennels and if the owners feel the dog looks sick, they may give it an injection to stimulate it, and make it more active. It usually lasts for about a week. They hope to sell the dog within a week to make their money, but the dog may die very soon after the week. If the buyer takes it to an animal hospital for treatment it may live. But if he doesn’t want to spend the money, it won’t.”

The serious — possibly deadly — illnesses include puppy distemper, canine parvovirus and canine coronavirus, usually contracted in dirty and crowded conditions at kennels.

Was Little Comrade a “one-week puppy,” as they are called?

Thankfully, the vet said he had only caught a cold. He tested negative for parvovirus and distemper, though he had been exposed to coronavirus, she said. Beijing’s cold had turned even harsher the weekend we bought him in early December, with temperatures dropping below freezing.

Still, the vet didn’t take any chances, administering anti-distemper serum and large amounts of antibiotics. The bottom line was — all puppies are vulnerable to serious disease because of the conditions they are often kept in before sale.

Overall, animal rights awareness here is low, said Ms. Xing.

“Many people are not responsible towards their pets,” she said. “They buy them as if they were toys. Then, once they have them back home, they feel they are difficult to care for because they urinate and defecate and they feel that’s dirty.”

“Some people throw their pets away when the family gets a baby,” she added. “When they’re abandoned some people do try to look for a new home. But many just throw them into the streets.”

As a result, animal shelters in Beijing and other cities are full.

“People’s consciousness about keeping pets needs to be raised,” Ms. Xing said. “They need to feel responsible for their lives.”

Read More..

AP PHOTOS: Top 10 Search Trends of 2012






NEW YORK (AP) — From the tragic to the downright silly, millions of people searched the Web in 2012 to find out about a royal princess, the latest iPad, a record-breaking skydiver and the death of a pop star.


Google released its 12th annual “zeitgeist” report on Wednesday. The company calls it “an in-depth look at the spirit of the times as seen through the billions of searches on Google over the past year.”






Here’s an Associated Press photo gallery of the top ten trending searches of 2012.


Gadgets News Headlines – Yahoo! News


Read More..

Eva Herzigová Expecting Third Child




Celebrity Baby Blog





12/12/2012 at 05:00 PM ET



BEva Herzigova Expecting Third Child
Dave M. Benett/Getty


This model mama is expanding her brood!


Eva Herzigová is five months pregnant with her third child, her agency Storm Models confirms to the Telegraph.


She and husband Gregorio Marsiaj will welcome the baby in the spring.


The new addition will join big brothers Philipe, 21 months, and George, 5.


One of the original supermodels — best-known for her Wonderbra ads — Herzigova, 39, continues to be a name in the industry.


She walked the runway just two weeks ago and is the new face of Dior Capture skincare.


– Sarah Michaud


Read More..

Congress examines science behind HGH test for NFL


WASHINGTON (AP) — A congressional committee has opened a hearing to examine the science behind a human growth hormone test the NFL wants to start using on its players.


Nearly two full seasons have passed since the league and the players' union signed a labor deal that set the stage for HGH testing.


The NFL Players Association won't concede the validity of a test that's used by Olympic sports and Major League Baseball, and the sides haven't been able to agree on a scientist to help resolve that impasse.


Among the witnesses before the House Oversight and Government Reform Committee on Wednesday is Pro Football Hall of Fame member Dick Butkus. In his prepared statement, Butkus writes: "Now, let's get on with it. The HGH testing process is proven to be reliable."


Read More..

Wall Street ends almost flat as Bernanke warns on "cliff"

NEW YORK (Reuters) - Stocks ended nearly flat on Wednesday, giving up most of the day's gains after Fed Chairman Ben Bernanke reiterated that monetary policy won't be enough to offset damage from the "fiscal cliff."


His comments followed the Federal Reserve's announcement of a new stimulus plan, which briefly pushed the S&P 500 to a seven-week high.


The plan, the latest attempt to boost the country's struggling economy, will replace a more modest program set to expire with a fresh round of Treasury purchases that will increase its balance sheet. The program is known as "quantitative easing" or QE.


In comments after the announcement, Bernanke said he hopes that markets won't have to tank to get a fiscal cliff deal.


"Initially the addition of QE was certainly favorable. I think, though, in the press conference, what came out is that there still seems to be a level of uncertainty with regard to the exit strategy (and) the efficacy of the current policy," said Bucky Hellwig, senior vice president at BB&T Wealth Management in Birmingham, Alabama.


Bernanke "reiterated the fact that monetary policy has its hands tied as far as addressing the seriousness of going over the fiscal cliff," Hellwig added.


The S&P financial sector index <.gspf>, which had been up more than 1 percent after the Fed's announcement, ended up just 0.5 percent.


Wal-Mart Stores Inc's stock was the biggest drag on the Dow, falling 2.8 percent to $68.94 following the Indian government's announcement of an inquiry into the company's lobbying practices.


The Dow Jones industrial average <.dji> slipped 2.99 points, or 0.02 percent, to 13,245.45 at the close. The Standard & Poor's 500 Index <.spx> inched up just 0.64 of a point, or 0.04 percent, to 1,428.48. But the Nasdaq Composite Index <.ixic> shed 8.49 points, or 0.28 percent, to end at 3,013.81.


Though the S&P 500 ended up just slightly, it was the sixth day of gains for the index - its longest winning streak since August.


The central bank committed to monthly purchases of $45 billion in Treasuries on top of the $40 billion per month in mortgage-backed bonds it started buying in September. It also said it will keep its near-zero interest-rate program in place until the U.S. unemployment rate falls to 6.5 percent from its current 7.7 percent.


"The actions by the Fed were more aggressive than investors anticipated," said Michael Sheldon, chief market strategist at RDM Financial in Westport, Connecticut.


"The asset-purchasing program is probably larger and more comprehensive than some might have thought."


Negotiations over plans to avoid the fiscal cliff intensified in Washington, but U.S. House of Representatives Speaker John Boehner said on Wednesday that "serious differences" remain with President Barack Obama in their talks. If no agreement is reached, steep tax hikes and budget cuts will fall into place early next year.


Shares of Aetna , the third-largest U.S. health insurer, gained 3.2 percent to $45.91, a day after the company gave a higher forecast for profit and revenue growth in 2013.


Volume was roughly 6.58 billion shares traded on the New York Stock Exchange, the Nasdaq and the NYSE MKT, compared with the year-to-date average daily closing volume of 6.52 billion.


Decliners slightly outnumbered advancers on the NYSE by about 16 to 15, and on the Nasdaq, by about 3 to 2.


(Reporting by Caroline Valetkevitch; Additional reporting by Leah Schnurr Editing by Jan Paschal)



Read More..

Mandela Is Suffering From Lung Infection


Alexander Joe/Agence France-Presse — Getty Images


In Soweto, an area of Johannesburg, a resident walked past images of Nelson Mandela, the 94-year-old former president of South Africa and hero of the antiapartheid movement, who remained hospitalized on Tuesday.







JOHANNESBURG — Former President Nelson Mandela, who has been hospitalized since Saturday, is suffering from a recurrence of a lung infection and is responding to treatment, the office of South Africa’s current president, Jacob Zuma, announced on Tuesday.




It was the first indication of Mr. Mandela’s medical condition since he was flown to Pretoria and taken to a hospital for unspecified tests over the weekend. It was his second hospitalization this year; in February he s checked into a hospital for tests to address a chronic stomach complaint, the government said at the time. He was released after minor diagnostic surgery, officials said.


Mr. Mandela, who is 94 and increasingly frail, was said by Mr. Zuma’s office to be “receiving appropriate treatment and he is responding to the treatment.”


The current stay in the hospital is the longest in recent memory, raising fears that Mr. Mandela’s condition is grave. Government officials have been upbeat about his prognosis while offering few details about his condition. Given his age, any infection is by its nature serious, medical experts say.


“I’m not sure we should press the panic button every single time a man of his age has the sniffles,” Mark Sonderup, vice chairman at the South African Medical Association, told The Mail and Guardian, a weekly newspaper, this week. “But unfortunately, we have to accept that simple health matters for a person of that age can turn very serious, very quickly.”


Mr. Mandela, South Africa’s first black president, has suffered from respiratory ailments for years, in part owing to the 27 years he spent in prison, most of it on Robben Island, working in a bleak quarry. He was diagnosed with tuberculosis in 1988 and had fluid drained from his lungs.


Mr. Mandela retired from public life some years ago, and was last seen publicly at the celebrations for the World Cup soccer tournament, which South Africa hosted in 2010, although he receives frequent visits from old friends and visiting dignitaries.


In January 2011, he was hospitalized for an acute respiratory infection, and the news of that illness set off a panic about his health.


When Secretary of State Hillary Rodham Clinton visited South Africa in August, she stopped by his home in the rural village of Qunu to see him. In a photograph of the two of them, Mr. Mandela beamed his trademark grin, but looked frail seated in an armchair and dressed in a gray cardigan.


Mr. Mandela led the African National Congress to a resounding victory in the first fully democratic elections in South Africa’s history in 1994, after successfully negotiating a peaceful transition from white rule. Despite harsh treatments at the hands of the apartheid government, Mr. Mandela advocated forgiveness and reconciliation, making him an icon of peacemaking the world over. After a single term as president, Mr. Mandela retired from politics in 1999.


Read More..

Megan Fox 'Screamed for an Epidural' During Delivery




Celebrity Baby Blog





12/11/2012 at 05:00 PM ET



Jenna Bush Hager Expecting First Child
John Shearer/Invision/AP


When it came to welcoming her first child, Megan Fox was prepared for the delivery to be a labor of love.


But one contraction later, and the actress’s dreams of being drug-free went out the window.


“It hurts so bad. It was so intense,” Fox, 26, told Access Hollywood during a press junket for her new movie, This Is 40.


“And I thought I was gonna be really tough and make it, I was going to labor to eight centimeters … but the first contraction I got was horrific!”


And with the pain level shooting sky-high from the start, Fox wasn’t shy about voicing her demands for medication to husband Brian Austin Green.

“I was screaming for an epidural when [Brian] was driving me to the hospital because my water broke on its own and immediately — it was level orange pain alert,” she recalls.


But, despite the unbearable pain, the first-time mom wanted to feel (and look!) her best for her baby boy’s big arrival.


“I was trying to blow dry my hair before I went to the hospital because I didn’t want to go to the hospital with wet hair,” she explains with a laugh.


Fortunately, all the pain — and primping! — paid off in a big way when the couple welcomed now 10-week-old Noah Shannon.


“It’s exhausting, but it’s amazing and you can’t — until you have kids — imagine how much you could possibly love a human being,” she shares of her “super cute” son.


“It’s really intense and really overwhelming and amazing.”


– Anya Leon


Read More..

APNewsBreak: DA investigating Texas cancer agency


AUSTIN, Texas (AP) — The Texas prosecutor responsible for investigating public corruption among state officials said Tuesday that he has opened an investigation into the state's troubled $3 billion cancer-fighting agency.


Gregg Cox, director of the Travis County district attorney's public integrity unit, told The Associated Press that an investigation has begun into the Cancer Prevention and Research Institute of Texas. The agency also is under investigation by the Texas attorney general's office after an $11 million grant to a private company did not receive the proper review.


Cox said his unit, which prosecutes crimes related to the operation of state government, is beginning its investigation not knowing "what, if any, crime occurred" at CPRIT.


His announcement came on the same day that CPRIT said its executive director had submitted his resignation letter and amid escalating scrutiny over the management of the nation's second-biggest pot of cancer research dollars.


CPRIT has not been able to focus on fighting the disease due to "wasted efforts expended in low value activities" during the past tumultuous eight months, Executive Director Bill Gimson wrote in a resignation letter dated Monday. Gimson offered to stay on until January, and the agency's board must still approve his request to step down.


Gimson has led the state agency since it launched in 2009. But he fell under mounting criticism over the recent disclosure that an $11 million award to a private company was never reviewed. It was the second time this year that a lucrative taxpayer-funded grant instigated backlash and raised questions about oversight.


"Unfortunately, I have also been placed in a situation where I feel I can no longer be effective," Gimson wrote.


The Texas attorney general's office has said it is looking into CPRIT's $11 million grant to Dallas-based Peloton Therapeutics. An internal audit performed by the agency revealed that Peloton's proposal was approved for funding in 2010 without being reviewed by an outside panel.


Gimson said last week that Peloton's funding was the result of an honest mistake that happened when the agency was still young and in the process of installing checks and balances. Agency emails surrounding the Peloton grant are no longer available, Gimson said, and state investigators said they will work to find them.


Only the National Institutes of Health doles out more cancer research dollars than CPRIT, which has awarded more than $700 million so far. The agency's former chief science officer, Nobel laureate Alfred Gilman, resigned earlier this year over a separate $20 million award that Gilman claimed received a thin review. That led some of the nation's top scientists to accuse the agency of charting a politically-driven path.


___


Follow Paul J. Weber on Twitter: www.twitter.com/pauljweber


Read More..